A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/7521652

Download in:

View as

General Info

PMID
7521652